Virtus Biotech Clinical Trials ETF (BBC) is a publicly traded company in the Financial Services sector, operating within the Asset Management industry.
BBC has IPO date of 2014-12-17, listed on the NYSE, a market capitalization of $36.78M.
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
